| Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic … SL James, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The Lancet 392 (10159), 1789-1858, 2018 | 8774 | 2018 |
| Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to … C Fitzmaurice, TF Akinyemiju, FH Al Lami, T Alam, R Alizadeh-Navaei, ... JAMA oncology 4 (11), 1553-1568, 2018 | 7022 | 2018 |
| Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of … GA Roth, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The Lancet 392 (10159), 1736-1788, 2018 | 6640 | 2018 |
| Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 study GA Roth, GA Mensah, CO Johnson, G Addolorato, E Ammirati, ... Journal of the American College of Cardiology 76 (25), 2982-3021, 2020 | 5938 | 2020 |
| Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and … JD Stanaway, A Afshin, E Gakidou, SS Lim, D Abate, KH Abate, ... The Lancet 392 (10159), 1923-1994, 2018 | 4445 | 2018 |
| Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990 … HH Kyu, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The Lancet 392 (10159), 1859-1922, 2018 | 3840 | 2018 |
| Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic … GBD 2016 Risk Factors Collaborators Lancet (London, England) 390 (10100), 1345, 2017 | 2758 | 2017 |
| Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 NJ Kassebaum, RM Barber, ZA Bhutta, L Dandona, PW Gething, SI Hay, ... The Lancet 388 (10053), 1775-1812, 2016 | 1183 | 2016 |
| Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the … NJ Kassebaum, M Arora, RM Barber, ZA Bhutta, J Brown, A Carter, ... The Lancet 388 (10053), 1603-1658, 2016 | 1026 | 2016 |
| Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis … JM Kocarnik, K Compton, FE Dean, W Fu, BL Gaw, JD Harvey, ... JAMA oncology 8 (3), 420-444, 2022 | 989 | 2022 |
| Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017 D Dicker, G Nguyen, D Abate, KH Abate, SM Abay, C Abbafati, N Abbasi, ... The lancet 392 (10159), 1684-1735, 2018 | 954 | 2018 |
| Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of … H Wang, AA Abajobir, KH Abate, C Abbafati, KM Abbas, F Abd-Allah, ... The Lancet 390 (10100), 1084-1150, 2017 | 873 | 2017 |
| Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of … H Wang, ZA Bhutta, MM Coates, M Coggeshall, L Dandona, K Diallo, ... The Lancet 388 (10053), 1725-1774, 2016 | 837 | 2016 |
| Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015 SS Lim, K Allen, ZA Bhutta, L Dandona, MH Forouzanfar, N Fullman, ... The Lancet 388 (10053), 1813-1850, 2016 | 653 | 2016 |
| Five insights from the Global Burden of Disease Study 2019 CJL Murray, C Abbafati, KM Abbas, M Abbasi, M Abbasi-Kangevari, ... The Lancet 396 (10258), 1135-1159, 2020 | 577 | 2020 |
| Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global … N Fullman, RM Barber, AA Abajobir, KH Abate, C Abbafati, KM Abbas, ... The Lancet 390 (10100), 1423-1459, 2017 | 403 | 2017 |
| Iran in transition G Danaei, F Farzadfar, R Kelishadi, A Rashidian, OM Rouhani, ... The Lancet 393 (10184), 1984-2005, 2019 | 192 | 2019 |
| N‐acetylcysteine augmentation therapy for moderate‐to‐severe obsessive–compulsive disorder: Randomized, double‐blind, placebo‐controlled trial K Paydary, A Akamaloo, A Ahmadipour, F Pishgar, S Emamzadehfard, ... Journal of clinical pharmacy and therapeutics 41 (2), 214-219, 2016 | 113 | 2016 |
| Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019 H Ebrahimi, Z Aryan, SS Moghaddam, C Bisignano, S Rezaei, F Pishgar, ... The Lancet Respiratory Medicine 9 (9), 1030-1049, 2021 | 108 | 2021 |
| Global, Regional and National Burden of Prostate Cancer, 1990–2015: Results from the Global Burden of Disease Study 2015 F Pishgar, H Ebrahimi, SS Moghaddam, C Fitzmaurice, E Amini The Journal of Urology 199 (5), 1224–1232, 2018 | 99 | 2018 |
